APO Research
Talk to an analyst

APO RESEARCH · REPORT

Urology Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Urology Drugs Market Analysis and Forecast 2026-2032

21 December 2025196 pages

Choose your research edition.

Industry ResearchUrology Drugs Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Urology Drugs Industry Growth and Trends Forecast to 203272 pages · $3,450 USDMarket StructureGlobal Urology Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Urology Drugs Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Urology Drugs Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Urology Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Urology Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Urology Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Urology Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Urology Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Urology Drugs include Endo, Astellas, Tolmar and GP Pharm, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Urology Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Urology Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Urology Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Urology Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Urology Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Urology Drugs sales, projected growth trends, production technology, application and end-user industry.

Urology Drugs Segment by Company

Endo

Astellas

Tolmar

GP Pharm

Urology Drugs Segment by Type

Α (alpha) Blockers

5 α-reductase Inhibitors

Urology Drugs Segment by Application

Hospital

Clinic

Others

Urology Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Urology Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Urology Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Urology Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Urology Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Urology Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Urology Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Urology Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Α (alpha) Blockers Major Manufacturers Table 3. 5 α-reductase Inhibitors Major Manufacturers Table 4. Global Urology Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Clinic Major Manufacturers Table 7. Others Major Manufacturers Table 8. Urology Drugs Industry Trends Table 9. Urology Drugs Industry Drivers Table 10. Urology Drugs Industry Opportunities and Challenges Table 11. Urology Drugs Industry Restraints Table 12. Global Urology Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Urology Drugs Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Urology Drugs Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Urology Drugs Revenue Market Share by Region (2021-2026) Table 16. Global Urology Drugs Revenue Market Share by Region (2027-2032) Table 17. Global Urology Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (tons) Table 18. Global Urology Drugs Sales by Region (2021-2026) & (tons) Table 19. Global Urology Drugs Sales by Region (2027-2032) & (tons) Table 20. Global Urology Drugs Sales Market Share by Region (2021-2026) Table 21. Global Urology Drugs Sales Market Share by Region (2027-2032) Table 22. Global Urology Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Urology Drugs Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Urology Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Urology Drugs Sales Market Share by Manufacturers (2021-2026) Table 26. Global Urology Drugs Sales Price (US$/kg) of Manufacturers (2021-2026) Table 27. Global Urology Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Urology Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Urology Drugs Manufacturers, Product Type & Application Table 30. Global Urology Drugs Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Urology Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Urology Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Urology Drugs Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Urology Drugs Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Urology Drugs Revenue Market Share by Type (2021-2026) Table 37. Global Urology Drugs Revenue Market Share by Type (2027-2032) Table 38. Global Urology Drugs Sales by Type 2021 VS 2025 VS 2032 (tons) Table 39. Global Urology Drugs Sales by Type (2021-2026) & (tons) Table 40. Global Urology Drugs Sales by Type (2027-2032) & (tons) Table 41. Global Urology Drugs Sales Market Share by Type (2021-2026) Table 42. Global Urology Drugs Sales Market Share by Type (2027-2032) Table 43. Global Urology Drugs Price by Type (2021-2026) & (US$/kg) Table 44. Global Urology Drugs Price by Type (2027-2032) & (US$/kg) Table 45. Global Urology Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Urology Drugs Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Urology Drugs Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Urology Drugs Revenue Market Share by Application (2021-2026) Table 49. Global Urology Drugs Revenue Market Share by Application (2027-2032) Table 50. Global Urology Drugs Sales by Application 2021 VS 2025 VS 2032 (tons) Table 51. Global Urology Drugs Sales by Application (2021-2026) & (tons) Table 52. Global Urology Drugs Sales by Application (2027-2032) & (tons) Table 53. Global Urology Drugs Sales Market Share by Application (2021-2026) Table 54. Global Urology Drugs Sales Market Share by Application (2027-2032) Table 55. Global Urology Drugs Price by Application (2021-2026) & (US$/kg) Table 56. Global Urology Drugs Price by Application (2027-2032) & (US$/kg) Table 57. Endo Company Information Table 58. Endo Business Overview Table 59. Endo Urology Drugs Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 60. Endo Urology Drugs Product Portfolio Table 61. Endo Recent Development Table 62. Astellas Company Information Table 63. Astellas Business Overview Table 64. Astellas Urology Drugs Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 65. Astellas Urology Drugs Product Portfolio Table 66. Astellas Recent Development Table 67. Tolmar Company Information Table 68. Tolmar Business Overview Table 69. Tolmar Urology Drugs Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 70. Tolmar Urology Drugs Product Portfolio Table 71. Tolmar Recent Development Table 72. GP Pharm Company Information Table 73. GP Pharm Business Overview Table 74. GP Pharm Urology Drugs Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 75. GP Pharm Urology Drugs Product Portfolio Table 76. GP Pharm Recent Development Table 77. North America Urology Drugs Revenue by Type (2021-2026) & (US$ Million) Table 78. North America Urology Drugs Revenue by Type (2027-2032) & (US$ Million) Table 79. North America Urology Drugs Sales by Type (2021-2026) & (tons) Table 80. North America Urology Drugs Sales by Type (2027-2032) & (tons) Table 81. North America Urology Drugs Sales Price by Type (2021-2026) & (US$/kg) Table 82. North America Urology Drugs Sales Price by Type (2027-2032) & (US$/kg) Table 83. North America Urology Drugs Revenue by Application (2021-2026) & (US$ Million) Table 84. North America Urology Drugs Revenue by Application (2027-2032) & (US$ Million) Table 85. North America Urology Drugs Sales by Application (2021-2026) & (tons) Table 86. North America Urology Drugs Sales by Application (2027-2032) & (tons) Table 87. North America Urology Drugs Sales Price by Application (2021-2026) & (US$/kg) Table 88. North America Urology Drugs Sales Price by Application (2027-2032) & (US$/kg) Table 89. North America Urology Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. North America Urology Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 91. North America Urology Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 92. North America Urology Drugs Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 93. North America Urology Drugs Sales by Country (2021-2026) & (tons) Table 94. North America Urology Drugs Sales by Country (2027-2032) & (tons) Table 95. North America Urology Drugs Sales Price by Country (2021-2026) & (US$/kg) Table 96. North America Urology Drugs Sales Price by Country (2027-2032) & (US$/kg) Table 97. United States Urology Drugs Revenue (2021-2032) & (US$ Million) Table 98. Canada Urology Drugs Revenue (2021-2032) & (US$ Million) Table 99. Mexico Urology Drugs Revenue (2021-2032) & (US$ Million) Table 100. Europe Urology Drugs Revenue by Type (2021-2026) & (US$ Million) Table 101. Europe Urology Drugs Revenue by Type (2027-2032) & (US$ Million) Table 102. Europe Urology Drugs Sales by Type (2021-2026) & (tons) Table 103. Europe Urology Drugs Sales by Type (2027-2032) & (tons) Table 104. Europe Urology Drugs Sales Price by Type (2021-2026) & (US$/kg) Table 105. Europe Urology Drugs Sales Price by Type (2027-2032) & (US$/kg) Table 106. Europe Urology Drugs Revenue by Application (2021-2026) & (US$ Million) Table 107. Europe Urology Drugs Revenue by Application (2027-2032) & (US$ Million) Table 108. Europe Urology Drugs Sales by Application (2021-2026) & (tons) Table 109. Europe Urology Drugs Sales by Application (2027-2032) & (tons) Table 110. Europe Urology Drugs Sales Price by Application (2021-2026) & (US$/kg) Table 111. Europe Urology Drugs Sales Price by Application (2027-2032) & (US$/kg) Table 112. Europe Urology Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. Europe Urology Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 114. Europe Urology Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 115. Europe Urology Drugs Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 116. Europe Urology Drugs Sales by Country (2021-2026) & (tons) Table 117. Europe Urology Drugs Sales by Country (2027-2032) & (tons) Table 118. Europe Urology Drugs Sales Price by Country (2021-2026) & (US$/kg) Table 119. Europe Urology Drugs Sales Price by Country (2027-2032) & (US$/kg) Table 120. Germany Urology Drugs Revenue (2021-2032) & (US$ Million) Table 121. France Urology Drugs Revenue (2021-2032) & (US$ Million) Table 122. U.K. Urology Drugs Revenue (2021-2032) & (US$ Million) Table 123. Italy Urology Drugs Revenue (2021-2032) & (US$ Million) Table 124. Russia Urology Drugs Revenue (2021-2032) & (US$ Million) Table 125. Spain Urology Drugs Revenue (2021-2032) & (US$ Million) Table 126. Netherlands Urology Drugs Revenue (2021-2032) & (US$ Million) Table 127. Switzerland Urology Drugs Revenue (2021-2032) & (US$ Million) Table 128. Sweden Urology Drugs Revenue (2021-2032) & (US$ Million) Table 129. Poland Urology Drugs Revenue (2021-2032) & (US$ Million) Table 130. China Urology Drugs Revenue by Type (2021-2026) & (US$ Million) Table 131. China Urology Drugs Revenue by Type (2027-2032) & (US$ Million) Table 132. China Urology Drugs Sales by Type (2021-2026) & (tons) Table 133. China Urology Drugs Sales by Type (2027-2032) & (tons) Table 134. China Urology Drugs Sales Price by Type (2021-2026) & (US$/kg) Table 135. China Urology Drugs Sales Price by Type (2027-2032) & (US$/kg) Table 136. China Urology Drugs Revenue by Application (2021-2026) & (US$ Million) Table 137. China Urology Drugs Revenue by Application (2027-2032) & (US$ Million) Table 138. China Urology Drugs Sales by Application (2021-2026) & (tons) Table 139. China Urology Drugs Sales by Application (2027-2032) & (tons) Table 140. China Urology Drugs Sales Price by Application (2021-2026) & (US$/kg) Table 141. China Urology Drugs Sales Price by Application (2027-2032) & (US$/kg) Table 142. Asia Urology Drugs Revenue by Type (2021-2026) & (US$ Million) Table 143. Asia Urology Drugs Revenue by Type (2027-2032) & (US$ Million) Table 144. Asia Urology Drugs Sales by Type (2021-2026) & (tons) Table 145. Asia Urology Drugs Sales by Type (2027-2032) & (tons) Table 146. Asia Urology Drugs Sales Price by Type (2021-2026) & (US$/kg) Table 147. Asia Urology Drugs Sales Price by Type (2027-2032) & (US$/kg) Table 148. Asia Urology Drugs Revenue by Application (2021-2026) & (US$ Million) Table 149. Asia Urology Drugs Revenue by Application (2027-2032) & (US$ Million) Table 150. Asia Urology Drugs Sales by Application (2021-2026) & (tons) Table 151. Asia Urology Drugs Sales by Application (2027-2032) & (tons) Table 152. Asia Urology Drugs Sales Price by Application (2021-2026) & (US$/kg) Table 153. Asia Urology Drugs Sales Price by Application (2027-2032) & (US$/kg) Table 154. Asia Urology Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 155. Asia Urology Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 156. Asia Urology Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 157. Asia Urology Drugs Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 158. Asia Urology Drugs Sales by Country (2021-2026) & (tons) Table 159. Asia Urology Drugs Sales by Country (2027-2032) & (tons) Table 160. Asia Urology Drugs Sales Price by Country (2021-2026) & (US$/kg) Table 161. Asia Urology Drugs Sales Price by Country (2027-2032) & (US$/kg) Table 162. Japan Urology Drugs Revenue (2021-2032) & (US$ Million) Table 163. South Korea Urology Drugs Revenue (2021-2032) & (US$ Million) Table 164. India Urology Drugs Revenue (2021-2032) & (US$ Million) Table 165. Australia Urology Drugs Revenue (2021-2032) & (US$ Million) Table 166. Taiwan Urology Drugs Revenue (2021-2032) & (US$ Million) Table 167. Southeast Asia Urology Drugs Revenue (2021-2032) & (US$ Million) Table 168. SAMEA Urology Drugs Revenue by Type (2021-2026) & (US$ Million) Table 169. SAMEA Urology Drugs Revenue by Type (2027-2032) & (US$ Million) Table 170. SAMEA Urology Drugs Sales by Type (2021-2026) & (tons) Table 171. SAMEA Urology Drugs Sales by Type (2027-2032) & (tons) Table 172. SAMEA Urology Drugs Sales Price by Type (2021-2026) & (US$/kg) Table 173. SAMEA Urology Drugs Sales Price by Type (2027-2032) & (US$/kg) Table 174. SAMEA Urology Drugs Revenue by Application (2021-2026) & (US$ Million) Table 175. SAMEA Urology Drugs Revenue by Application (2027-2032) & (US$ Million) Table 176. SAMEA Urology Drugs Sales by Application (2021-2026) & (tons) Table 177. SAMEA Urology Drugs Sales by Application (2027-2032) & (tons) Table 178. SAMEA Urology Drugs Sales Price by Application (2021-2026) & (US$/kg) Table 179. SAMEA Urology Drugs Sales Price by Application (2027-2032) & (US$/kg) Table 180. SAMEA Urology Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 181. SAMEA Urology Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 182. SAMEA Urology Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 183. SAMEA Urology Drugs Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 184. SAMEA Urology Drugs Sales by Country (2021-2026) & (tons) Table 185. SAMEA Urology Drugs Sales by Country (2027-2032) & (tons) Table 186. SAMEA Urology Drugs Sales Price by Country (2021-2026) & (US$/kg) Table 187. SAMEA Urology Drugs Sales Price by Country (2027-2032) & (US$/kg) Table 188. Brazil Urology Drugs Revenue (2021-2032) & (US$ Million) Table 189. Argentina Urology Drugs Revenue (2021-2032) & (US$ Million) Table 190. Chile Urology Drugs Revenue (2021-2032) & (US$ Million) Table 191. Colombia Urology Drugs Revenue (2021-2032) & (US$ Million) Table 192. Peru Urology Drugs Revenue (2021-2032) & (US$ Million) Table 193. Saudi Arabia Urology Drugs Revenue (2021-2032) & (US$ Million) Table 194. Israel Urology Drugs Revenue (2021-2032) & (US$ Million) Table 195. UAE Urology Drugs Revenue (2021-2032) & (US$ Million) Table 196. Turkey Urology Drugs Revenue (2021-2032) & (US$ Million) Table 197. Iran Urology Drugs Revenue (2021-2032) & (US$ Million) Table 198. Egypt Urology Drugs Revenue (2021-2032) & (US$ Million) Table 199. Key Raw Materials Table 200. Raw Materials Key Suppliers Table 201. Urology Drugs Distributors List Table 202. Urology Drugs Customers List Table 203. Research Programs/Design for This Report Table 204. Authors List of This Report Table 205. Secondary Sources Table 206. Primary Sources List of Figures Figure 1. Urology Drugs Image Figure 2. Global Urology Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Urology Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Α (alpha) Blockers Image Figure 5. 5 α-reductase Inhibitors Image Figure 6. Global Urology Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Urology Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Others Image Figure 11. Global Urology Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Urology Drugs Revenue (2021-2032) & (US$ Million) Figure 13. Global Urology Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Urology Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Urology Drugs Revenue Market Share by Region (2021-2032) Figure 16. Global Urology Drugs Sales (2021-2032) & (tons) Figure 17. Global Urology Drugs Sales by Region: 2021 VS 2025 VS 2032 (tons) Figure 18. Global Urology Drugs Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Urology Drugs Sales YoY (2021-2032) & (tons) Figure 20. Europe Urology Drugs Sales YoY (2021-2032) & (tons) Figure 21. China Urology Drugs Sales YoY (2021-2032) & (tons) Figure 22. Asia (Excluding China) Urology Drugs Sales YoY (2021-2032) & (tons) Figure 23. South America, Middle East and Africa Urology Drugs Sales YoY (2021-2032) & (tons) Figure 24. Global Urology Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Urology Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Urology Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Urology Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Urology Drugs Revenue Market Share by Type (2021-2032) Figure 30. Global Urology Drugs Sales by Type (2021 VS 2025 VS 2032) & (tons) Figure 31. Global Urology Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Urology Drugs Sales Market Share by Type (2021-2032) Figure 33. Global Urology Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Urology Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Urology Drugs Revenue Market Share by Application (2021-2032) Figure 36. Global Urology Drugs Sales by Application (2021 VS 2025 VS 2032) & (tons) Figure 37. Global Urology Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Urology Drugs Sales Market Share by Application (2021-2032) Figure 39. North America Urology Drugs Revenue Share by Type (2021-2032) Figure 40. North America Urology Drugs Sales Share by Type (2021-2032) Figure 41. North America Urology Drugs Revenue Share by Application (2021-2032) Figure 42. North America Urology Drugs Sales Share by Application (2021-2032) Figure 43. North America Urology Drugs Revenue Share by Country (2021-2032) Figure 44. North America Urology Drugs Sales Share by Country (2021-2032) Figure 45. Europe Urology Drugs Revenue Share by Type (2021-2032) Figure 46. Europe Urology Drugs Sales Share by Type (2021-2032) Figure 47. Europe Urology Drugs Revenue Share by Application (2021-2032) Figure 48. Europe Urology Drugs Sales Share by Application (2021-2032) Figure 49. Europe Urology Drugs Revenue Share by Country (2021-2032) Figure 50. Europe Urology Drugs Sales Share by Country (2021-2032) Figure 51. China Urology Drugs Revenue Share by Type (2021-2032) Figure 52. China Urology Drugs Sales Share by Type (2021-2032) Figure 53. China Urology Drugs Revenue Share by Application (2021-2032) Figure 54. China Urology Drugs Sales Share by Application (2021-2032) Figure 55. Asia Urology Drugs Revenue Share by Type (2021-2032) Figure 56. Asia Urology Drugs Sales Share by Type (2021-2032) Figure 57. Asia Urology Drugs Revenue Share by Application (2021-2032) Figure 58. Asia Urology Drugs Sales Share by Application (2021-2032) Figure 59. Asia Urology Drugs Revenue Share by Country (2021-2032) Figure 60. Asia Urology Drugs Sales Share by Country (2021-2032) Figure 61. SAMEA Urology Drugs Revenue Share by Type (2021-2032) Figure 62. SAMEA Urology Drugs Sales Share by Type (2021-2032) Figure 63. SAMEA Urology Drugs Revenue Share by Application (2021-2032) Figure 64. SAMEA Urology Drugs Sales Share by Application (2021-2032) Figure 65. SAMEA Urology Drugs Revenue Share by Country (2021-2032) Figure 66. SAMEA Urology Drugs Sales Share by Country (2021-2032) Figure 67. Urology Drugs Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Urology Drugs Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Α (alpha) Blockers
  • 5 α-reductase Inhibitors
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Endo
  • Astellas
  • Tolmar
  • GP Pharm

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Urology Drugs Market by Type
  3. 1.2.1 Global Urology Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Α (alpha) Blockers
  5. 1.2.3 5 α-reductase Inhibitors
  6. 1.3 Urology Drugs Market by Application
  7. 1.3.1 Global Urology Drugs Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Urology Drugs Market Dynamics
  1. 2.1 Urology Drugs Industry Trends
  2. 2.2 Urology Drugs Industry Drivers
  3. 2.3 Urology Drugs Industry Opportunities and Challenges
  4. 2.4 Urology Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Urology Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Urology Drugs Revenue by Region
  3. 3.2.1 Global Urology Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Urology Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Urology Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Urology Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Urology Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Urology Drugs Sales by Region
  9. 3.4.1 Global Urology Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Urology Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Urology Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Urology Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Urology Drugs Revenue by Manufacturers
  2. 4.1.1 Global Urology Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Urology Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Urology Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Urology Drugs Sales by Manufacturers
  6. 4.2.1 Global Urology Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Urology Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Urology Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Urology Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Urology Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Urology Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Urology Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Urology Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Urology Drugs Market CR5 and HHI
  16. 4.8.2 2025 Urology Drugs Tier 1, Tier 2, and Tier 3
5 Urology Drugs Market by Type
  1. 5.1 Global Urology Drugs Revenue by Type
  2. 5.1.1 Global Urology Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Urology Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Urology Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Urology Drugs Sales by Type
  6. 5.2.1 Global Urology Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Urology Drugs Sales by Type (2021-2032) & (tons)
  8. 5.2.3 Global Urology Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Urology Drugs Price by Type
6 Urology Drugs Market by Application
  1. 6.1 Global Urology Drugs Revenue by Application
  2. 6.1.1 Global Urology Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Urology Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Urology Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Urology Drugs Sales by Application
  6. 6.2.1 Global Urology Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Urology Drugs Sales by Application (2021-2032) & (tons)
  8. 6.2.3 Global Urology Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Urology Drugs Price by Application
7 Company Profiles
  1. 7.1 Endo
  2. 7.1.1 Endo Company Information
  3. 7.1.2 Endo Business Overview
  4. 7.1.3 Endo Urology Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Endo Urology Drugs Product Portfolio
  6. 7.1.5 Endo Recent Developments
  7. 7.2 Astellas
  8. 7.2.1 Astellas Company Information
  9. 7.2.2 Astellas Business Overview
  10. 7.2.3 Astellas Urology Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Astellas Urology Drugs Product Portfolio
  12. 7.2.5 Astellas Recent Developments
  13. 7.3 Tolmar
  14. 7.3.1 Tolmar Company Information
  15. 7.3.2 Tolmar Business Overview
  16. 7.3.3 Tolmar Urology Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Tolmar Urology Drugs Product Portfolio
  18. 7.3.5 Tolmar Recent Developments
  19. 7.4 GP Pharm
  20. 7.4.1 GP Pharm Company Information
  21. 7.4.2 GP Pharm Business Overview
  22. 7.4.3 GP Pharm Urology Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 GP Pharm Urology Drugs Product Portfolio
  24. 7.4.5 GP Pharm Recent Developments
8 North America
  1. 8.1 North America Urology Drugs Market Size by Type
  2. 8.1.1 North America Urology Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Urology Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Urology Drugs Price by Type (2021-2032)
  5. 8.2 North America Urology Drugs Market Size by Application
  6. 8.2.1 North America Urology Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Urology Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Urology Drugs Price by Application (2021-2032)
  9. 8.3 North America Urology Drugs Market Size by Country
  10. 8.3.1 North America Urology Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Urology Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Urology Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Urology Drugs Market Size by Type
  2. 9.1.1 Europe Urology Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Urology Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Urology Drugs Price by Type (2021-2032)
  5. 9.2 Europe Urology Drugs Market Size by Application
  6. 9.2.1 Europe Urology Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Urology Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Urology Drugs Price by Application (2021-2032)
  9. 9.3 Europe Urology Drugs Market Size by Country
  10. 9.3.1 Europe Urology Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Urology Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Urology Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Urology Drugs Market Size by Type
  2. 10.1.1 China Urology Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Urology Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Urology Drugs Price by Type (2021-2032)
  5. 10.2 China Urology Drugs Market Size by Application
  6. 10.2.1 China Urology Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Urology Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Urology Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Urology Drugs Market Size by Type
  2. 11.1.1 Asia Urology Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Urology Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Urology Drugs Price by Type (2021-2032)
  5. 11.2 Asia Urology Drugs Market Size by Application
  6. 11.2.1 Asia Urology Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Urology Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Urology Drugs Price by Application (2021-2032)
  9. 11.3 Asia Urology Drugs Market Size by Country
  10. 11.3.1 Asia Urology Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Urology Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Urology Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Urology Drugs Market Size by Type
  2. 12.1.1 SAMEA Urology Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Urology Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Urology Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Urology Drugs Market Size by Application
  6. 12.2.1 SAMEA Urology Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Urology Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Urology Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Urology Drugs Market Size by Country
  10. 12.3.1 SAMEA Urology Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Urology Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Urology Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Urology Drugs Value Chain Analysis
  2. 13.1.1 Urology Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Urology Drugs Production Mode & Process
  6. 13.2 Urology Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Urology Drugs Distributors
  9. 13.2.3 Urology Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst